Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Retained Earnings (2022 - 2025)

Historic Retained Earnings for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to -$801.2 million.

  • Immunocore Holdings' Retained Earnings fell 378.57% to -$801.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$801.2 million, marking a year-over-year decrease of 378.57%. This contributed to the annual value of -$795.8 million for FY2024, which is 686.03% down from last year.
  • Latest data reveals that Immunocore Holdings reported Retained Earnings of -$801.2 million as of Q3 2025, which was down 378.57% from -$801.0 million recorded in Q2 2025.
  • Immunocore Holdings' 5-year Retained Earnings high stood at -$689.4 million for Q4 2022, and its period low was -$801.2 million during Q3 2025.
  • For the 4-year period, Immunocore Holdings' Retained Earnings averaged around -$771.6 million, with its median value being -$780.7 million (2024).
  • Its Retained Earnings has fluctuated over the past 5 years, first tumbled by 801.97% in 2023, then crashed by 260.17% in 2025.
  • Quarter analysis of 4 years shows Immunocore Holdings' Retained Earnings stood at -$689.4 million in 2022, then decreased by 8.02% to -$744.7 million in 2023, then fell by 6.86% to -$795.8 million in 2024, then fell by 0.69% to -$801.2 million in 2025.
  • Its last three reported values are -$801.2 million in Q3 2025, -$801.0 million for Q2 2025, and -$790.7 million during Q1 2025.